Abie Alias, Ernesto J Rodriguez, Helen E Bateman, Ashley G Sterrett, Joanne Valeriano-Marcet
{"title":"风湿病学和肿瘤学:恶性肿瘤的风湿病表现和抗肿瘤治疗的最新综述。","authors":"Abie Alias, Ernesto J Rodriguez, Helen E Bateman, Ashley G Sterrett, Joanne Valeriano-Marcet","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Review of the literature addressing the rheumatic manifestations of various malignancies as well as of common chemotherapeutic agents.</p><p><strong>Methods: </strong>A literature search was performed to identify key articles regarding the association of rheumatic disease with malignancy.</p><p><strong>Results: </strong>Our review focused on the association of rheumatic disease with malignancy, paraneoplastic syndromes with rheumatic manifestations, and chemotherapeutic agents related to rheumatic syndromes. We have discussed the importance of a newly described autoantibody that may identify patients at risk for malignancy associated myositis.</p><p><strong>Conclusion: </strong>Based on our literature review, recommendations are suggested regarding who and how patients should be screened for malignancy when presenting with various rheumatic symptoms.</p>","PeriodicalId":72485,"journal":{"name":"Bulletin of the NYU hospital for joint diseases","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2012-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Rheumatology and oncology: an updated review of rheumatic manifestations of malignancy and anti-neoplastictherapy.\",\"authors\":\"Abie Alias, Ernesto J Rodriguez, Helen E Bateman, Ashley G Sterrett, Joanne Valeriano-Marcet\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objective: </strong>Review of the literature addressing the rheumatic manifestations of various malignancies as well as of common chemotherapeutic agents.</p><p><strong>Methods: </strong>A literature search was performed to identify key articles regarding the association of rheumatic disease with malignancy.</p><p><strong>Results: </strong>Our review focused on the association of rheumatic disease with malignancy, paraneoplastic syndromes with rheumatic manifestations, and chemotherapeutic agents related to rheumatic syndromes. We have discussed the importance of a newly described autoantibody that may identify patients at risk for malignancy associated myositis.</p><p><strong>Conclusion: </strong>Based on our literature review, recommendations are suggested regarding who and how patients should be screened for malignancy when presenting with various rheumatic symptoms.</p>\",\"PeriodicalId\":72485,\"journal\":{\"name\":\"Bulletin of the NYU hospital for joint diseases\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2012-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Bulletin of the NYU hospital for joint diseases\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bulletin of the NYU hospital for joint diseases","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Rheumatology and oncology: an updated review of rheumatic manifestations of malignancy and anti-neoplastictherapy.
Objective: Review of the literature addressing the rheumatic manifestations of various malignancies as well as of common chemotherapeutic agents.
Methods: A literature search was performed to identify key articles regarding the association of rheumatic disease with malignancy.
Results: Our review focused on the association of rheumatic disease with malignancy, paraneoplastic syndromes with rheumatic manifestations, and chemotherapeutic agents related to rheumatic syndromes. We have discussed the importance of a newly described autoantibody that may identify patients at risk for malignancy associated myositis.
Conclusion: Based on our literature review, recommendations are suggested regarding who and how patients should be screened for malignancy when presenting with various rheumatic symptoms.
分享
京公网安备 11010802042870号
京ICP备2023020795号-1
求助内容：
应助结果提醒方式：
扫码关注我们
